Transce3nd, LLC: EGRIX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Transce3nd, LLC on EGRIX, newest first. How the timeline and the estimate are built.
Transce3nd, LLC held 15,358 EGRIX shares at 2026-09-30 per its 13F-HR filed 2026-10-26.
the latest 13F is the newest step
- period ended2026-09-3013F 15,358 sharesChange vs previous 13F -3,569 shares
0.2% of the 13F portfolio, value $200,263.
13F-HR 0002023570-26-000005 filed by Transce3nd, LLC
Accepted , ingested - period ended2026-06-3013F 18,927 sharesChange vs previous 13F -1,980 shares
2.12% of the 13F portfolio, value $240,369.
13F-HR 0002023570-26-000004 filed by Transce3nd, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 20,907 sharesChange vs previous 13F -1,011 shares
2.24% of the 13F portfolio, value $252,769.
13F-HR 0002023570-26-000002 filed by Transce3nd, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 21,918 sharesChange vs previous 13F -5,789 shares
2.15% of the 13F portfolio, value $266,305.
13F-HR 0002023570-26-000001 filed by Transce3nd, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 27,707 sharesChange vs previous 13F -3,423 shares
2.82% of the 13F portfolio, value $315,325.
13F-HR 0002023570-25-000007 filed by Transce3nd, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 31,130 sharesChange vs previous 13F not available
0.15% of the 13F portfolio, value $358,019.
13F-HR 0002023570-25-000005 filed by Transce3nd, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).